RU93002452A - METHOD OF TREATMENT OF CHRONIC POLYPOSAL HYMORITIS - Google Patents

METHOD OF TREATMENT OF CHRONIC POLYPOSAL HYMORITIS

Info

Publication number
RU93002452A
RU93002452A RU93002452/14A RU93002452A RU93002452A RU 93002452 A RU93002452 A RU 93002452A RU 93002452/14 A RU93002452/14 A RU 93002452/14A RU 93002452 A RU93002452 A RU 93002452A RU 93002452 A RU93002452 A RU 93002452A
Authority
RU
Russia
Prior art keywords
muscle
day
polyposal
hymoritis
chronic
Prior art date
Application number
RU93002452/14A
Other languages
Russian (ru)
Other versions
RU2033794C1 (en
Inventor
Т.А. Костарев
С.В. Панова
Original Assignee
Красноярский государственный медицинский институт
Filing date
Publication date
Application filed by Красноярский государственный медицинский институт filed Critical Красноярский государственный медицинский институт
Priority to RU93002452A priority Critical patent/RU2033794C1/en
Priority claimed from RU93002452A external-priority patent/RU2033794C1/en
Application granted granted Critical
Publication of RU2033794C1 publication Critical patent/RU2033794C1/en
Publication of RU93002452A publication Critical patent/RU93002452A/en

Links

Claims (1)

Изобретение относится к области медицины, а именно к отоларингологии, и может быть использовано в ЛОР - клиниках. Целью изобретения является сокращение количества послеоперационных осложнений. Способ включает хирургическое удаление полипов. Новым в способе является то, что за пять дней до хирургической коррекции и в течение двух недель после операции больному назначают следующий медикаментозный комплекс: дибазол перорально 0,02 г два раза в сутки за 30 минут до еды, 3% раствор витамина В1 1 мл в мышцу N 10 через день, 5% раствор витамина В6 1 мл в мышцу N 10 через день, экстракт алоэ 1 мл в мышцу N 20 ежедневно.The invention relates to the field of medicine, namely to otolaryngology, and can be used in ENT clinics. The aim of the invention is to reduce the number of postoperative complications. The method includes the surgical removal of polyps. New in the method is that five days before the surgical correction and within two weeks after the operation the patient is prescribed the following drug complex: Dibazol 0.02 g orally twice a day 30 minutes before meals, 3% solution of vitamin B 1 1 ml in muscle N 10 every other day, 5% solution of vitamin B 6 1 ml in muscle N 10 every other day, aloe extract 1 ml in muscle N 20 daily.
RU93002452A 1993-01-13 1993-01-13 Method of curing chronic polypous sinusitis RU2033794C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU93002452A RU2033794C1 (en) 1993-01-13 1993-01-13 Method of curing chronic polypous sinusitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93002452A RU2033794C1 (en) 1993-01-13 1993-01-13 Method of curing chronic polypous sinusitis

Publications (2)

Publication Number Publication Date
RU2033794C1 RU2033794C1 (en) 1995-04-30
RU93002452A true RU93002452A (en) 1995-11-20

Family

ID=20135698

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93002452A RU2033794C1 (en) 1993-01-13 1993-01-13 Method of curing chronic polypous sinusitis

Country Status (1)

Country Link
RU (1) RU2033794C1 (en)

Similar Documents

Publication Publication Date Title
RU94027680A (en) Parathyroid hormone and raloxifen for bone mass increase, pharmaceutical composition and method of osseous mass increase
RU94041198A (en) Imidazopyridazine derivatives, process for preparation thereof, pharmaceutical composition containing said derivatives, and process for preparation thereof
ATE319457T1 (en) TREATMENT OF IATROGENIC AND AGE-RELATED HYPERTENSION WITH VITAMIN B6 DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS USABLE THEREFOR
RU2349336C2 (en) Compositions for arthritis state treatment
KR970061244A (en) Pharmaceutical composition for treating dementia
HENCH Effect of jaundice on chronic infectious (atrophic) arthritis and on primary fibrositis: further observations; attempts to reproduce the phenomenon
RU95101385A (en) Products containing g-csf and tnf-binding protein
RU2000114174A (en) APPLICATION OF PHOSPHOLIPID COMPLEXES OF EXTRACTS FROM VITIS VINIFERA AS ANTIATHEROSCLEROTIC AGENTS
BR9712964A (en) Agreement packaging and method to improve or assist patient compliance for complex drug diets.
PT100415A (en) NEW PHARMACEUTICAL ACID MORPHOLINS, AND PROCESS FOR THEIR PREPARATION
RU93002452A (en) METHOD OF TREATMENT OF CHRONIC POLYPOSAL HYMORITIS
US4150123A (en) Method for treating gastro intestinal ulcers with extract of herb cetraria
ATE207353T1 (en) USE OF BENZYDAMINE TO TREAT MEDICAL CONDITIONS CAUSED BY TNF
RU93005465A (en) METHOD OF TREATING ACUTE RESPIRATORY DISEASES
Akdeniz et al. Garlic: Friend or Enemy?
SU1754113A1 (en) Method for treatment of acute enteric infections in children
SU1703118A1 (en) Method for treating the cases of herpetic stomatitis in children
RU96120000A (en) METHOD FOR TREATING INFECTIO-ALLERGIC RHINOSYNOSOPATHY
RU2018309C1 (en) Agent for treatment of false joints of long tubular bones
RU2019183C1 (en) Blood plateletcytopoiesis stimulator
RU93005464A (en) METHOD FOR PREOPERATIVE PREPARATION OF OTHORINOLARYNGOLOGICAL PATIENTS
Calin The elusive triad
RU94038588A (en) Method of secondary immunodeficiency treatment
RU94036169A (en) Method for treating hepatitis
RU94036344A (en) Method for treating aids cases